Your browser is no longer supported. Please, upgrade your browser.
Avantor, Inc.
Index- P/E85.38 EPS (ttm)0.45 Insider Own0.60% Shs Outstand582.60M Perf Week0.18%
Market Cap22.85B Forward P/E25.33 EPS next Y1.52 Insider Trans-56.33% Shs Float566.60M Perf Month-12.28%
Income266.60M PEG3.59 EPS next Q0.32 Inst Own90.60% Short Float2.90% Perf Quarter4.20%
Sales7.04B P/S3.25 EPS this Y110.70% Inst Trans0.46% Short Ratio4.43 Perf Half Y15.06%
Book/sh3.40 P/B11.30 EPS next Y11.71% ROA2.60% Target Price42.95 Perf Year50.96%
Cash/sh0.37 P/C102.47 EPS next 5Y23.80% ROE15.20% 52W Range22.49 - 44.37 Perf YTD36.48%
Dividend- P/FCF25.27 EPS past 5Y- ROI6.30% 52W High-13.41% Beta-
Dividend %- Quick Ratio1.10 Sales past 5Y58.60% Gross Margin33.10% 52W Low70.83% ATR1.06
Employees12400 Current Ratio1.80 Sales Q/Q25.70% Oper. Margin7.80% RSI (14)40.86 Volatility2.14% 2.73%
OptionableYes Debt/Eq2.85 EPS Q/Q216.90% Profit Margin3.80% Rel Volume1.01 Prev Close38.77
ShortableYes LT Debt/Eq2.83 EarningsOct 28 AMC Payout170.40% Avg Volume3.71M Price38.42
Recom1.60 SMA20-3.66% SMA50-4.88% SMA20012.91% Volume3,763,593 Change-0.90%
Oct-15-21Resumed Cowen Outperform $62 → $47
Aug-30-21Resumed Raymond James Outperform $45
Aug-05-21Resumed Credit Suisse Outperform $42
Aug-02-21Upgrade Piper Sandler Neutral → Overweight $40 → $45
Jun-04-21Initiated Goldman Buy $40
Apr-29-21Upgrade Stifel Hold → Buy $40
Mar-03-21Initiated Barclays Overweight $33
Nov-10-20Initiated KeyBanc Capital Markets Overweight $33
Sep-14-20Initiated Morgan Stanley Overweight $24
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jan-08-20Initiated Wells Fargo Overweight $22
Jan-07-20Initiated Citigroup Buy $21
Nov-15-19Initiated Stifel Hold
Aug-02-19Initiated Cleveland Research Neutral
Jun-14-19Initiated Janney Buy $27
Jun-12-19Initiated Raymond James Outperform $20
Jun-11-19Initiated William Blair Outperform
Jun-11-19Initiated UBS Buy $21
Jun-11-19Initiated SunTrust Buy $22
Jun-11-19Initiated Robert W. Baird Outperform $20
Oct-22-21 11:03AM  
Oct-21-21 04:10PM  
Oct-19-21 05:52PM  
Oct-14-21 10:00AM  
Oct-12-21 04:13PM  
Oct-11-21 12:10PM  
Oct-04-21 12:11PM  
Sep-30-21 09:12AM  
Sep-28-21 06:37AM  
Sep-23-21 06:44AM  
Sep-22-21 06:54AM  
Sep-21-21 06:37AM  
Sep-16-21 10:21AM  
Sep-13-21 08:54PM  
Sep-10-21 09:15AM  
Sep-07-21 04:27PM  
Aug-31-21 08:25AM  
Aug-30-21 04:11PM  
Jul-31-21 03:55AM  
Jul-30-21 04:30PM  
Jul-29-21 06:05PM  
Jul-26-21 09:15AM  
Jul-22-21 03:03PM  
Jul-20-21 08:25AM  
Jul-16-21 08:25AM  
Jul-08-21 09:15AM  
Jul-06-21 09:06AM  
Jun-25-21 08:00AM  
Jun-22-21 04:50PM  
Jun-21-21 12:43PM  
Jun-18-21 12:00PM  
Jun-17-21 09:15AM  
Jun-16-21 11:12AM  
Jun-10-21 04:32PM  
Jun-02-21 08:09AM  
Jun-01-21 04:05PM  
May-27-21 09:26AM  
May-26-21 08:05AM  
May-20-21 07:29PM  
May-19-21 04:05PM  
May-18-21 08:37AM  
May-14-21 01:43AM  
May-04-21 02:00PM  
May-03-21 09:29AM  
Apr-29-21 08:23AM  
Apr-28-21 04:05PM  
Apr-27-21 04:05PM  
Apr-26-21 01:26PM  
Apr-22-21 05:17PM  
Apr-21-21 12:34PM  
Apr-14-21 05:46PM  
Apr-13-21 05:18PM  
Apr-12-21 09:12AM  
Apr-08-21 11:57AM  
Apr-07-21 04:07PM  
Mar-31-21 04:05PM  
Mar-23-21 10:49AM  
Mar-18-21 04:21PM  
Mar-15-21 01:27AM  
Feb-26-21 06:26PM  
Feb-23-21 04:56PM  
Feb-22-21 06:03PM  
Feb-10-21 08:37AM  
Feb-03-21 09:00PM  
Feb-02-21 08:37AM  
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUPTA RAJIVDirectorOct 01Sale39.94100,0003,994,0001,079,347Oct 04 05:28 PM
Stubblefield MichaelPresident and CEOSep 20Sale42.37141,3005,986,8811,261,981Sep 22 05:16 PM
GUPTA RAJIVDirectorSep 01Sale39.45100,0003,945,0001,179,347Sep 02 05:55 PM
Eck Steven WSVP & Chief Accounting OfficerAug 26Sale40.0817,383696,71114,148Aug 27 04:18 PM
GUPTA RAJIVDirectorAug 20Sale38.81100,0003,881,0001,279,347Aug 23 05:26 PM
Brophy GerardEVP, Biopharma ProductionJul 30Option Exercise23.2081,1251,882,100230,504Aug 02 04:42 PM
Brophy GerardEVP, Biopharma ProductionJul 30Sale37.2481,1253,021,095149,379Aug 02 04:42 PM
Bramwell JamesEVP, Strategic PartnersJul 20Sale37.006,112226,14479,899Jul 21 05:04 PM
Natauri JoDirectorJul 12Buy36.3330010,900557,656Aug 13 05:10 PM
Bramwell JamesEVP, Strategic PartnersJul 09Sale35.6118,331652,82886,011Jul 13 05:32 PM
Couturier ChristopheEVP, AMEAJun 28Sale35.7328,0961,003,870110,077Jun 29 05:11 PM
GUPTA RAJIVDirectorJun 25Sale35.3268,6052,423,1291,379,347Jun 28 04:55 PM
Stubblefield MichaelPresident and CEOJun 10Option Exercise3.7499,887373,4641,460,656Jun 10 06:55 PM
Stubblefield MichaelPresident and CEOJun 10Sale32.4899,8873,244,3301,403,281Jun 10 06:55 PM
Stubblefield MichaelPresident and CEOJun 09Option Exercise3.13235,170736,0821,638,451Jun 10 06:55 PM
Stubblefield MichaelPresident and CEOJun 09Sale32.03235,1707,532,4951,403,281Jun 10 06:55 PM
Stubblefield MichaelPresident and CEOJun 08Option Exercise3.13152,643477,7731,555,924Jun 10 06:55 PM
Stubblefield MichaelPresident and CEOJun 08Sale32.04152,6434,890,6821,403,281Jun 10 06:55 PM
Ohri DevashishEVP, IMEAMay 27Option Exercise23.21100,0002,321,000239,095May 28 04:48 PM
Ohri DevashishEVP, IMEAMay 27Sale31.99100,0003,199,000139,095May 28 04:48 PM
GUPTA RAJIVDirectorMay 27Sale31.9478,1092,494,801278,109May 28 04:48 PM
Ohri DevashishEVP, IMEAMay 26Option Exercise23.2115,000348,150154,095May 27 04:53 PM
Ohri DevashishEVP, IMEAMay 26Sale31.8715,000478,050139,095May 27 04:53 PM
GUPTA RAJIVDirectorMay 26Sale31.89150,0004,783,500356,218May 28 04:48 PM
Ohri DevashishEVP, IMEAMay 24Option Exercise17.679,124161,221148,219May 25 05:08 PM
GUPTA RAJIVDirectorMay 24Sale31.66337,57110,687,716506,218May 26 05:43 PM
Ohri DevashishEVP, IMEAMay 24Sale31.759,124289,687139,095May 25 05:08 PM
Wondrasch MichaelEVP & CIOMay 21Sale31.4118,488580,708113,295May 24 05:14 PM
Miller JustinEVP & General CounselMay 20Sale31.1218,488575,34786,536May 21 04:55 PM
Brophy GerardEVP, Biopharma ProductionMay 20Sale31.1019,603609,653149,379May 21 04:54 PM
Couturier ChristopheEVP, AMEAMay 20Sale31.1325,010778,561138,173May 21 04:55 PM
Ohri DevashishEVP, IMEAMay 14Option Exercise23.2125,000580,250180,888May 17 05:37 PM
Natauri JoDirectorMay 11Sale30.682,626,77180,589,33424,807,518May 13 05:47 PM
Ohri DevashishEVP, IMEAApr 30Option Exercise23.2153,6491,245,193209,537May 04 05:06 PM
Ohri DevashishEVP, IMEAApr 30Sale32.5853,6491,747,884155,888May 04 05:06 PM
Miller JustinEVP & General CounselApr 12Option Exercise23.21100,0002,321,000218,679Apr 13 06:02 PM
Ohri DevashishEVP, IMEAApr 12Option Exercise1.60100,160160,256256,048Apr 13 06:03 PM
Bramwell JamesEVP, Strategic PartnersApr 12Sale32.002,50580,160118,136Apr 13 06:02 PM
Vanderhaegen FredericEVP, EuropeApr 12Sale31.8027,075860,997216,594Apr 13 06:03 PM
Miller JustinEVP & General CounselApr 12Sale33.17102,8953,412,916118,679Apr 13 06:02 PM
Ohri DevashishEVP, IMEAApr 12Sale32.37100,1603,242,179155,888Apr 13 06:03 PM
Vanderhaegen FredericEVP, EuropeMar 09Sale28.2110,000282,100243,669Mar 10 05:08 PM
Wondrasch MichaelEVP & CIOMar 02Sale28.713,03687,164145,438Mar 03 05:11 PM
Eck Steven WSVP & Chief Accounting OfficerFeb 24Option Exercise0.008,550028,532Feb 26 06:44 PM
Brophy GerardEVP, Biopharma ProductionFeb 24Sale27.933,05985,438172,384Feb 26 06:34 PM
Brophy GerardEVP, Biopharma ProductionFeb 22Option Exercise17.6719,769349,318195,212Feb 23 05:51 PM
Brophy GerardEVP, Biopharma ProductionFeb 22Sale28.6219,769565,789175,443Feb 23 05:51 PM
Wondrasch MichaelEVP & CIOFeb 05Option Exercise23.2040,000928,000181,543Feb 08 06:23 PM
Wondrasch MichaelEVP & CIOFeb 05Sale29.7749,4681,472,662141,543Feb 08 06:23 PM
Brophy GerardEVP, Biopharma ProductionJan 11Option Exercise23.20378,5808,783,056394,847Jan 13 05:41 PM
Bramwell JamesEVP, Strategic PartnersJan 11Sale30.002,50575,150116,430Jan 13 05:43 PM
Brophy GerardEVP, Biopharma ProductionJan 11Sale30.06378,58011,381,196178,515Jan 13 05:41 PM
Brophy GerardEVP, Biopharma ProductionJan 06Sale27.2411,509313,505178,515Jan 08 07:31 PM
Brophy GerardEVP, Biopharma ProductionJan 04Option Exercise18.4559,4181,096,262249,442Jan 06 09:06 PM
Brophy GerardEVP, Biopharma ProductionJan 04Sale27.8459,4181,654,197190,024Jan 06 09:06 PM
Bramwell JamesEVP, Strategic PartnersDec 21Sale27.1410,020271,943117,768Dec 23 05:10 PM
Shaw ChristiDirectorDec 11Sale26.6814,286381,15011,319Dec 15 07:16 PM
Stubblefield MichaelPresident and CEODec 07Option Exercise1.60210,369336,5901,945,717Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 07Sale27.4598,4522,702,5071,847,265Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 04Option Exercise1.60880,6011,408,9622,147,536Dec 08 07:09 PM
Stubblefield MichaelPresident and CEODec 04Sale27.08412,18811,162,0511,735,348Dec 08 07:09 PM
New Mountain Investments III, 10% OwnerNov 10Sale24.8136,016,093893,490,83728,000,000Nov 10 09:24 PM